what is a retatrutide Significantly Reduces Visceral Fat in Clinical Trials Retatrutide - GLP-1 / GIP
Description
If proven effective in clinical trials, this approach could improve convenience, treatment adherence, and possibly even tolerability for many patients
Higher starting doses do not accelerate results and typically increase nausea, vomiting, or constipation that actually delays adherence and slows progress
The best next step is speaking with a qualified medical provider who understands both medical weight loss and peptide-based wellness approaches
"Tesamorelin for the treatment of HIV-associated lipodystrophy." Ther Clin Risk Manag
Dry mouth: The medication can cause dry mouth, which may increase the risk of dental problems
